New Zealand vs Sao Tome and Principe: Treatment success rate for patients treated for MDR-TB
New Zealand
100.0%
in 2022
Sao Tome and Principe
100.0%
in 2022
New Zealand rank
1st
Sao Tome and Principe rank
1st
Treatment success rate for patients treated for MDR-TB over time
- New Zealand
- Sao Tome and Principe
How they compare
New Zealand currently reports 100.0% against 100.0% in Sao Tome and Principe, a difference of 0.0%.
The two have swapped places 4 times across 10 shared years of data; in 2011 it was Sao Tome and Principe ahead.
New Zealand ranks 1st and Sao Tome and Principe ranks 1st of 163 countries.
Across the 2 decades both report, New Zealand averaged higher in 1 and Sao Tome and Principe in 1.
Head to head by decade
| Decade | New Zealand | Sao Tome and Principe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 61.9% | 77.6% | 15.7% | Sao Tome and Principe |
| 2020s | 100.0% | 55.7% | 44.3% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, New Zealand or Sao Tome and Principe?
- New Zealand, at 100.0% against 100.0% in Sao Tome and Principe as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between New Zealand and Sao Tome and Principe?
- 0.0%, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and Sao Tome and Principe?
- 10 years are reported by both, from 2011 to 2022.
- How do New Zealand and Sao Tome and Principe rank globally for treatment success rate for patients treated for mdr-tb?
- New Zealand ranks 1st and Sao Tome and Principe ranks 1st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.